Akebia Therapeutics (AKBA)

Add to Watchlists
Create an Alert
13.82 +0.15  +1.10% NASDAQ Jul 21, 20:00 Delayed 2m USD
View Full Chart
AKBA Price Chart
View All Events

AKBA Events

Date Type Description
03/06/2017 Misc Akebia Therapeutics Inc Fourth Quarter Earnings Conference Call in 2016
03/06/2017 Earnings Akebia Therapeutics Inc Fourth Quarter Earnings in 2016 Release
11/09/2016 Earnings Akebia Therapeutics Inc Third Quarter Earnings Results in 2016
08/08/2016 Earnings Akebia Therapeutics Inc Second Quarter Earnings Results in 2016
View All Performance Charts

AKBA Total Returns Comparison

Advertisement

AKBA One Page Reports

Edit

Profile

  • URL: http://www.akebia.com
  • Investor Relations URL: http://ir.akebia.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Next Earnings Release: N/A
  • Last Earnings Release: Mar. 06, 2017
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics for patients based on hypoxia inducible factor, biology and the commercialization of these products for patients with renal disease.

AKBA Comparables

Edit

AKBA Excel Add-In Codes

  • Name: =YCI("AKBA","name")
  • Description: =YCI("AKBA","description")
  • Sector: =YCI("AKBA","sector")
  • Industry: =YCI("AKBA","industry")
  • Est. Current Fiscal Year End: =YCI("AKBA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.